Status:
COMPLETED
Lower Extremity Evaluation in Children With Diparetic Cerebral Palsy According to ICF Perspective
Lead Sponsor:
Acıbadem Atunizade Hospital
Conditions:
Diparesis
Cerebral Palsy
Eligibility:
All Genders
3-13 years
Brief Summary
Cerebral palsy (CP); is the most common neurodevelopmental disorder seen in childhood, characterized by permanent motor dysfunctions that develop due to brain damage occurring before birth, during bir...
Detailed Description
It's an observational study. Purpose of the study: The increase in tone seen in the lower extremities in children with diparetic cerebral palsy (DCP) may adversely affect the activity and participati...
Eligibility Criteria
Inclusion
- Between 3-13 years old,
- Diagnosis of diparetic cerebral palsy,
- Participants and/or parents willing to participate in the study voluntarily.
Exclusion
- Having different types of CP such as dyskinetic, mixed, ataxic types other than spastic type,
- Having spastic quadriparetic or hemiparetic type CP,
- Having received Botulinum Toxin injections to the lower extremities within the last 6 months.
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06583746
Start Date
January 1 2002
End Date
January 31 2022
Last Update
September 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acıbadem Altunizade Hospital
Istanbul, Turkey (Türkiye)